Archive - February 2018
Faslodex rejected by NICE for NHS breast cancer use
Array BioPharma demands $192m after AstraZeneca refuses to pay royalties
In wine, there’s health: Low levels of alcohol good for the brain
Athenahealth misses 2017 bookings goal
Breast cancer patients barred from NHS access to Faslodex
Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years
AstraZeneca, Array BioPharma cancer deal results in lawsuit
Super Bowl Snacks That Don’t Put Health on the Sidelines